Pycap has acquired an equity position in SMYLS, a Canadian SaaS solution aimed at simplifying uninsured physician billing, enhancing its commitment to innovative healthcare technology investments.
Information on the Target: SMYLS
SMYLS is a Canadian-based, modern SaaS solution designed to streamline the often-complex process of uninsured and block billing for family physicians. The platform was developed in response to real challenges faced by healthcare practitioners, specifically the co-founder’s spouse—a physician who experienced difficulties with traditional uninsured billing practices at her clinic. This led to the creation of a user-friendly system, built by a team of experienced technologists, focused on simplifying billing processes for medical professionals.
The core capabilities of SMYLS include rapid invoicing and payment processing, automated block billing, and customizable pricing structures tailored to each physician. These features enable clinics to improve operational efficiency, enhance cash flow, and ultimately increase annual revenue—some users reporting boosts of over $100,000 per physician.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Canada
The healthcare technology landscape in Canada is rapidly evolving, driven largely by advancements in digital health solutions aimed at improving patient care and administrative efficiencies. Market demand for technology-enable
Similar Deals
Pycap
invested in
SMYLS
in 2025
in a Other VC deal